Trials / Completed
CompletedNCT02091271
Screening Protocol to Evaluate Volunteers for NIA Approved Studies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- National Institute on Aging (NIA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The National Institute on Aging (NIA) Intramural Research Program (IRP) has a number ofiRB approved research studies involving human subjects, both normal volunteers and patients. As a means of identifying interested volunteers and other participants in the research process, this screening mechanism is established to identif'y potential eligible participants for NlA protocols. To participate, volunteers/patients must meet the specific requirements of at least one of the available NlA research studies; this protocol serves as a first step for admitting volunteers/patients to an appropriate approved protocol and creating a contact database for approved NlA studies. This protocol will facilitate their recruitment into NIA approved studies and provide NlA staff the opportunity to examine subjects where diagnostic observations can be documented and evaluated for research potential.
Detailed description
The screening protocol is designed to evaluate volunteers/patients for participation in IRB approved clinical studies of the National Institute on Aging (NIA). An additional purpose of this protocol is to develop a registry of individuals who have been evaluated through the NIA Clinical Research Unit screening clinic. To participate, volunteers/patients must meet the specific requirements of at least one of the available NIA research studies. This protocol serves as a first step for admitting volunteers/patients to an appropriate approved protocol, and it is used to develop a registry of individuals who meet eligibility criteria for existing research projects.
Conditions
Timeline
- Start date
- 2003-02-28
- Primary completion
- 2020-03-11
- Completion
- 2020-03-11
- First posted
- 2014-03-19
- Last updated
- 2020-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02091271. Inclusion in this directory is not an endorsement.